Vaxcyte Balance Sheet Health
Financial Health criteria checks 6/6
Vaxcyte has a total shareholder equity of $3.4B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $3.6B and $142.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.18b |
| Equity | US$3.42b |
| Total liabilities | US$142.11m |
| Total assets | US$3.56b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 5VA's short term assets ($2.2B) exceed its short term liabilities ($123.8M).
Long Term Liabilities: 5VA's short term assets ($2.2B) exceed its long term liabilities ($18.3M).
Debt to Equity History and Analysis
Debt Level: 5VA is debt free.
Reducing Debt: 5VA has no debt compared to 5 years ago when its debt to equity ratio was 1.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 5VA has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 5VA has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 50.3% each year